HEPA
Hepion Pharmaceuticals
HEPA
HEPA
Delisted
HEPA was delisted on the 12th of May, 2025.
10 hedge funds and large institutions have $957K invested in Hepion Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 8 funds opening new positions, increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
10
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$325K | |
| 2 | +$231K | |
| 3 | +$92K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$74K |
| 5 |
PFS
Prospera Financial Services
Dallas,
Texas
|
+$70K |
Top Sellers
| 1 | -$278K | |
| 2 | -$46K | |
| 3 | -$15.8K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$6K |